Clinical Trial Update: Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of KP-1461 in ART-experienced HIV patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• KP-1461

Snippet

Sponsor: Koronis Pharmaceuticals. | Conditions: HIV Infections | Phase 2 | Status: TERMINATED